137 related articles for article (PubMed ID: 8811343)
1. HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.
Beretta A; Furci L; Burastero S; Cosma A; Dinelli ME; Lopalco L; DeSantis C; Tambussi G; Carrow E; Sabbatani S; Clerici M; Lazzarin A; Siccardi AG
Immunol Lett; 1996 Jun; 51(1-2):39-43. PubMed ID: 8811343
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.
Burastero SE; Gaffi D; Lopalco L; Tambussi G; Borgonovo B; De Santis C; Abecasis C; Robbioni P; Gasparri A; Lazzarin A; Celada F; Siccardi AG; Beretta A
AIDS Res Hum Retroviruses; 1996 Mar; 12(4):273-80. PubMed ID: 8906987
[TBL] [Abstract][Full Text] [Related]
3. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
[TBL] [Abstract][Full Text] [Related]
4. The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed people.
Brown L; Souberbielle BE; Marriott JB; Westby M; Desselberger U; Kaye T; Gougeon ML; Dalgleish A
AIDS; 1999 Dec; 13(18):2515-21. PubMed ID: 10630520
[TBL] [Abstract][Full Text] [Related]
5. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
6. The high frequency of HIV type 1-specific cellular immune responses in seronegative individuals with parenteral and/or heterosexual HIV type 1 exposure.
Murashev BV; Nazarenko OV; Akulova EB; Artemyeva AK; Verevochkin SV; Shaboltas AV; Skochilov RV; Toussova OV; Kozlov AP
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1598-605. PubMed ID: 22475222
[TBL] [Abstract][Full Text] [Related]
7. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
Lopalco L; Barassi C; Pastori C; Longhi R; Burastero SE; Tambussi G; Mazzotta F; Lazzarin A; Clerici M; Siccardi AG
J Immunol; 2000 Mar; 164(6):3426-33. PubMed ID: 10706739
[TBL] [Abstract][Full Text] [Related]
8. HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein.
Carrillo J; Restrepo C; Rallón NI; Massanella M; del Romero J; Rodríguez C; Soriano V; Clotet B; Benito JM; Blanco J
AIDS; 2013 Jun; 27(9):1375-85. PubMed ID: 23945502
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes.
Liegler TJ; Stites DP
J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):340-8. PubMed ID: 7907660
[TBL] [Abstract][Full Text] [Related]
10. T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals.
Vyakarnam A; Matear PM; Cranenburg C; Michie C; Beverley PC; Wahren B; Gill SK; Weller I
Int Immunol; 1991 Oct; 3(10):939-47. PubMed ID: 1721834
[TBL] [Abstract][Full Text] [Related]
11. Association between anti-CD4 antibodies and a decline in CD4+ lymphocytes in human immunodeficiency virus type 1 seroconverters.
Keay S; Wecksler W; Wasserman SS; Margolick J; Farzadegan H
J Infect Dis; 1995 Feb; 171(2):312-9. PubMed ID: 7844366
[TBL] [Abstract][Full Text] [Related]
12. HIV-specific antibodies but not t-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia.
Nguyen M; Pean P; Lopalco L; Nouhin J; Phoung V; Ly N; Vermisse P; Henin Y; Barré-Sinoussi F; Burastero SE; Reynes JM; Carcelain G; Pancino G
J Acquir Immune Defic Syndr; 2006 Aug; 42(4):412-9. PubMed ID: 16837821
[TBL] [Abstract][Full Text] [Related]
13. Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner.
Promadej N; Costello C; Wernett MM; Kulkarni PS; Robison VA; Nelson KE; Hodge TW; Suriyanon V; Duerr A; McNicholl JM
J Infect Dis; 2003 Apr; 187(7):1053-63. PubMed ID: 12660919
[TBL] [Abstract][Full Text] [Related]
14. Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans.
Kang CY; Nara P; Chamat S; Caralli V; Ryskamp T; Haigwood N; Newman R; Köhler H
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6171-5. PubMed ID: 2068099
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.
Beretta A; Weiss SH; Rappocciolo G; Mayur R; De Santis C; Quirinale J; Cosma A; Robbioni P; Shearer GM; Berzofsky JA
J Infect Dis; 1996 Feb; 173(2):472-6. PubMed ID: 8568315
[TBL] [Abstract][Full Text] [Related]
16. Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition - A Nested Case-Control Study in HIV-1 Serodiscordant Couples.
Suchard MS; Martinson N; Malfeld S; de Assis Rosa D; Mackelprang RD; Lingappa J; Hou X; Rees H; Delany-Moretlwe S; Goldfein H; Ranchod H; Coetzee D; Otwombe K; Morris L; Tiemessen CT; Savulescu DM
Front Immunol; 2022; 13():813412. PubMed ID: 35401581
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin.
Lopalco L; Barassi C; Paolucci C; Breda D; Brunelli D; Nguyen M; Nouhin J; Luong TT; Truong LX; Clerici M; Calori G; Lazzarin A; Pancino G; Burastero SE
J Gen Virol; 2005 Feb; 86(Pt 2):339-348. PubMed ID: 15659753
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.
Furci L; Beretta A; Siccardi A; Lazzarin A; Confetti C; Magnani Z; Scarpellini P; Lopalco L; Burastero SE
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1461-9. PubMed ID: 9390745
[TBL] [Abstract][Full Text] [Related]
19. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
[TBL] [Abstract][Full Text] [Related]
20. Idiotypic expression of anti-gp120 antibodies in unrelated human immunodeficiency virus-infected individuals.
Février M; Boudet F; Corre JP; Chamaret S; Thèze J; Zouali M
J Gen Virol; 1992 Oct; 73 ( Pt 10)():2561-8. PubMed ID: 1383396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
